The expression of PD-L1 in ESCC tumor cells was positive in 29.9% (113/378), which was associated with various clinicopathological parameters including age, degree of differentiation, T stage, N stage and metachronous hematogenous metastasis. The gene discussed is CD274; the disease is neoplasm.